Avacta Group Plc (LON:AVCT – Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 57.07 ($0.74) and traded as high as GBX 61 ($0.79). Avacta Group shares last traded at GBX 56 ($0.73), with a volume of 1,710,026 shares traded.
Avacta Group Trading Down 3.4 %
The stock has a market capitalization of £200.65 million, a P/E ratio of -622.22 and a beta of 1.12. The stock’s 50 day moving average price is GBX 63.46 and its 200-day moving average price is GBX 57.07. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 63.54.
Insider Buying and Selling at Avacta Group
In related news, insider Tony Peter Gardiner sold 500,000 shares of the firm’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of GBX 71 ($0.92), for a total transaction of £355,000 ($460,919.24). Insiders own 32.90% of the company’s stock.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Further Reading
- Five stocks we like better than Avacta Group
- What is a buyback in stocks? A comprehensive guide for investors
- Texas Roadhouse Stock Steering for New Highs This Year
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Why Invest in 5G? How to Invest in 5G Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.